Omkar Pharmachem logo

Omkar Pharmachem

OMKARPHARMACHEMLTD NSE

Key Fundamentals

MicrocapCommodity ChemicalsChemicals
Market Cap
₹7.24 Cr
Volatility
Low Risk
P/E Ratio
94.6
EBITDA
₹0.20 Cr
Return on Equity
0.33%
Debt to Equity
0
Book Value
₹36.33
52W High
₹29.74
52W Low
₹7.57

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

4
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 0.21 times its book value
  • Debtor days have improved from 41.6 to 23.3 days.

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 11.7% over past five years.
  • Promoter holding is low: 0.03%
  • Company has a low return on equity of 1.23% over last 3 years.

Growth Rate

Revenue Growth
0% higher than 3Y
Net Income Growth
-50% lower than 3Y
Cash Flow Change
-4.17% higher than 3Y
ROE
-84.51% lower than 3Y
ROCE
-85.2% higher than 3Y
EBITDA Margin (Avg.)
-33.92% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0.14
0.14
0.14
0.14
0.14
0.14
0.14
0.14
0.14
0.14
0.11
0.09
0.09
Expenses
0.09
0.05
0.07
0.06
0.09
0.05
0.05
0.07
0.1
0.07
0.07
0.07
0.1
Operating Profit
0.05
0.09
0.07
0.08
0.05
0.09
0.09
0.07
0.04
0.07
0.04
0.02
-0.01
OPM %
35.71%
64.29%
50%
57.14%
35.71%
64.29%
64.29%
50%
28.57%
50%
36.36%
22.22%
-11.11%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0.03
0
0
0
0.02
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0.05
0.09
0.07
0.05
0.05
0.09
0.09
0.05
0.04
0.07
0.04
0.02
-0.01
Tax %
0%
0%
0%
120%
0%
0%
0%
140%
25%
28.57%
25%
0%
0%
Net Profit
0.05
0.09
0.07
-0.02
0.05
0.09
0.08
-0.02
0.03
0.05
0.03
0.02
-0.01
EPS in Rs
0.05
0.09
0.07
-0.02
0.05
0.09
0.08
-0.02
0.03
0.05
0.03
0.02
-0.01
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
0
0
0
0
0.05
0.27
0.54
0.54
0.54
0.54
0.47
0.43
Expenses
0.06
0.12
0.22
0.24
0.38
0.26
0.24
0.27
0.22
0.25
0.24
0.31
0.31
Operating Profit
-0.06
-0.12
-0.22
-0.24
-0.38
-0.21
0.03
0.27
0.32
0.29
0.3
0.16
0.12
OPM %
—
—
—
—
—
-420%
11.11%
50%
59.26%
53.7%
55.56%
34.04%
27.91%
Other Income
0
0
0.49
0
0
0
0
0
0
0
0
0.01
0
Interest
0
0
0
0.01
0.04
0.05
0.06
0.06
0.05
0.03
0.02
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0.01
0
0
PBT
-0.06
-0.12
0.27
-0.25
-0.42
-0.26
-0.03
0.21
0.27
0.26
0.27
0.17
0.12
Tax %
0%
0%
18.52%
0%
0%
0%
-866.67%
14.29%
25.93%
23.08%
25.93%
23.53%
—
Net Profit
-0.06
-0.12
0.22
-0.26
-0.42
-0.26
0.22
0.18
0.2
0.19
0.2
0.12
0.09
EPS in Rs
-0.06
-0.12
0.22
-0.26
-0.42
-0.26
0.22
0.18
0.2
0.19
0.2
0.12
0.09
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
10.08
10.08
10.08
10.08
10.08
10.08
10.08
10.08
10.08
10.08
10.08
10.08
Reserves
-0.81
-0.93
-0.71
-0.96
-1.38
-1.64
-1.42
-1.24
-1.04
-0.85
-0.65
26.56
Borrowings
0.01
0
0
0.24
0.58
0.87
0.9
0.93
0.62
0.3
0.12
0
Other Liabilities
0.13
0.57
0.06
0.04
0.05
0.06
0.08
0.06
0.07
0.07
0.05
0.05
Total Liabilities
9.41
9.72
9.43
9.4
9.33
9.37
9.64
9.83
9.73
9.6
9.6
36.69
Fixed Assets
0.01
0.01
0
0.01
0
0
0
0.01
0
0.01
0.01
0
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
9.3
9.3
9.3
9.3
9.3
9.3
9.3
9.3
9.3
9.3
9.3
36.38
Other Assets
0.1
0.41
0.13
0.09
0.03
0.07
0.34
0.52
0.43
0.29
0.29
0.31
Total Assets
9.41
9.72
9.43
9.4
9.33
9.37
9.64
9.83
9.73
9.6
9.6
36.69
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.05
0.34
-0.77
-0.25
-0.3
-0.21
0.02
0.2
0.28
0.3
0.24
0.23
Investing
0
0
0.49
-0.01
0
0
0
-0.01
0
-0.01
0
0
Financing
0
-0.01
0.01
0.23
0.3
0.24
-0.02
-0.03
-0.35
-0.35
-0.2
-0.12
Net Cash Flow
-0.05
0.33
-0.28
-0.03
0
0.02
0
0.17
-0.08
-0.06
0.04
0.11
Free Cash Flow
-0.05
0.34
-0.29
-0.26
-0.3
-0.21
0.02
0.19
0.28
0.29
0.24
0.23
CFO/OP
83
-283
327
104
79
100
67
74
88
103
80
150
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
—
—
—
—
—
146
40.56
54.07
87.87
33.8
67.59
23.3
Cash Conversion Cycle
—
—
—
—
—
146
40.56
54.07
87.87
33.8
67.59
23.3
Working Capital Days
—
—
—
—
—
-6,570
-1,271
-608
-379
-162
-6.76
23.3
ROCE %
-0.64%
-1.3%
-2.27%
-2.56%
-4.08%
-2.26%
0.32%
2.79%
3.29%
3.02%
3.04%
0.74%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Omkar Pharmachem insights

55 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Shareholding Pattern

Public98.36%Promot.0.03%Others1.61%As ofJun 2026

Documents

Frequently Asked Questions about Omkar Pharmachem

What does Omkar Pharmachem Ltd do?
Incorporated in 1995, Omkar Pharmachem Ltd provides business support services.[1]
Where is Omkar Pharmachem Ltd (532167) listed?
Omkar Pharmachem Ltd trades as OMKARPHARMACHEMLTD on the NSE and under code 532167 on the BSE.
Which sector does Omkar Pharmachem Ltd belong to?
Omkar Pharmachem Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the market capitalisation of Omkar Pharmachem Ltd?
Omkar Pharmachem Ltd has a market capitalisation of ₹7.24 Cr, which places it in the Small Cap band.
What is the PE ratio of Omkar Pharmachem Ltd?
Omkar Pharmachem Ltd trades at a PE ratio of 94.60, against a book value of ₹36.33 per share.
What is the 52-week high and low of Omkar Pharmachem Ltd?
Over the last 52 weeks Omkar Pharmachem Ltd has traded between ₹7.57 and ₹29.74.
What is the Return on Equity (ROE) of Omkar Pharmachem Ltd?
Omkar Pharmachem Ltd reported a return on equity of 0.33%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1995, Omkar Pharmachem Ltd provides business support services.[1]

Website omkarpharmachem.co.in
Listed 2006-11-23
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/532167.md for Omkar Pharmachem Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List